Renal Cancer - Results from #260

REVIEW UroToday

Analysis of surgical complications of renal tumor enucleation with standardized instruments and external validation of PADUA classification, "Beyond the Abstract," by Andrea Minervini, MD, PhD, et al August 12, 2013

Another look at treatment choices for metastatic renal cell carcinoma, "Beyond the Abstract," by Ghieth A. Kazkaz, et al. July 25, 2013

Short-term functional and oncological outcomes of partial nephrectomy for renal cell carcinoma in patients with an anatomically or functionally solitary kidney, "Beyond the Abstract," by Takeshi Maehana, MD, and Toshiaki Tanaka, MD July 18, 2013

Liver transplant techniques in surgical management of renal cell carcinoma with inferior vena cava thrombus, "Beyond the Abstract," by Michael Garcia-Roig, MD and Gaetano Ciancio, MD June 28, 2013

Preoperative evaluation of perinephric fat invasion in patients with renal cell carcinoma: Correlation with pathologic findings, "Beyond the Abstract," by Sandeep S. Hedgire, MD, et al June 25, 2013

Dual-tracer PET/CT in renal angiomyolipoma and subtypes of renal cell carcinoma, "Beyond the Abstract," by Kwan-Lun Ho, MBBS, Kossen Man Tzit Ho, MD, PhD, and Chi-lai Ho, MD June 22, 2013

A case-control study of insulin resistance and risk of renal cell cancer, "Beyond the Abstract," by Themistoklis N. Spyridopoulos, MD, PHD, et al June 20, 2013

The Sapporo Medical University School of Medicine experience: Resection of the inferior vena cava for urological malignancies, "Beyond the Abstract," by Toshiaki Tanaka June 11, 2013

"Beyond the Abstract," Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: A RECORD-1 subgroup analysis, by Sergio Bracarda, MD May 17, 2013

Synchronous melanoma and renal carcinoma: A clinicopathological study of five cases, "Beyond the Abstract," by Rubeta N. Matin, PhD, BSc (HONS), MBBS, MRCP May 3, 2013

Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies, "Beyond the Abstract," by PD Dr. med. Silke Potthast April 26, 2013

Renal functional and perioperative outcomes of off-clamp versus clamped robot-assisted partial nephrectomy: Matched cohort study, "Beyond the Abstract," by Sherb Figenshau, MD April 25, 2013

A concise review of the efficacy of stereotactic radiosurgery in the management of melanoma and renal cell carcinoma brain metastases, "Beyond the Abstract," by Christopher M. Lee, MD April 22, 2013

Off-clamp robot-assisted partial nephrectomy for complex renal tumors, "Beyond the Abstract," by Eric H. Kim, MD, et al March 19, 2013

A validated tumorgraft model reveals activity of dovitinib against renal cell carcinoma, "Beyond the Abstract," by James Brugarolas, MD, PhD March 18, 2013

What is the optimal therapy for patients with metastatic renal cell carcinoma who progress on an initial VEGFr-TKI? "Beyond the Abstract," by Emiliano Calvo, MD, PhD March 11, 2013

Treating patients with metastatic renal carcinoma: An escape from Phase III, "Beyond the Abstract," by Fable Zustovich, MD, et al March 8, 2013

Predicting the histology of small renal masses using preoperative dynamic contrast-enhanced magnetic resonance imaging, "Beyond the Abstract," by Jae Young Park, MD March 2, 2013

Immunotherapy and targeted therapies in metastatic renal cell carcinoma: Is there a preferred sequence? "Beyond the Abstract," by Jacopo Giuliani, MD February 11, 2013

Prognostic factors in renal cell carcinoma: Analysis of 227 patients treated at the Brazilian National Cancer Institute, "Beyond the Abstract," by Antonio Augusto Ornellas, MD, PhD January 31, 2013

Page 14 of 16